OncoSec Medical to Present New Clinical Data at Melanoma Bridge 2014

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, will present new data from clinical studies evaluating the Company’s ImmunoPulse immunotherapy in patients with melanoma at Melanoma Bridge 2014.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1EhRgbD

via IFTTT